ArticleBMC plant biology2025
Phyto-synthesis, characterization of silver nanoparticles from mint leaf extract and its evaluation in antimicrobial and pharmacological applications.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- An intelligent delivery system for apricot preservation: pH-responsive hollow ZIF-8 loaded with lavender essential oil and its preservation efficacy.Food chemistry: X · 2026Article
- Green synthesis of silver nanoparticles using Solanum melongena peel and Abelmoschus esculentus extracts: a dual study on antibacterial efficacy and photocatalytic activity.Scientific reports · 2026Article
- Green-synthesized silver nanoparticles from Camellia sinensis: mechanistic insights into phenolic-mediated multifunctional biological activities.BMC plant biology · 2025Article
- The Role of a Newly Synthesized Antimicrobial Peptide (KK)International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mentha arvensis is an important medicinal herb possess strong therapeutic values, including antioxidant, anti-inflammatory, hepatoprotective, antiulcer, cardioprotective, anticancer, and antimicrobial properties. Also, nanotechnology is an emerging multidisciplinary science having multiple applications in different fields. Based on the medicinal properties of the M. arvensis and applications of the nanoparticles, the current work was focused on the biogenically synthesized AgNPs. The Prepared NPs were characterized via UV-visible spectrometry, Flame Atomic Absorption Spectroscopy (FAAS), X-ray diffraction (XRD) analysis, scanning electron microscopy (SEM), and energy dispersive X-ray spectroscopy (EDX). UV-visible spectral investigation showed an absorption reading peak at 434 nm due to surface plasmon resonance, indicating phyto-reduction. XRD spectrum revealed the crystalline-like nature and average size of AgNPs ranging from 2.5-47.3 nm. SEM micrograph represented the spherical, irregular, and aggregated nature of AgNPs. EDX graph evidenced 68.6% of elemental Ag sample material, hence confirming the phyto-reduction. Biogenically synthesized AgNPs have shown considerable anti-microbial action against gram-negative and positive strains of bacteria. The highest zone of inhibition (ZOI) was detected on higher concentrations of AgNPs towards E. coli, Pseudomonas aeruginosa, Enterobacter aerogenes, and Acetobacter sicerae (14 ± 1.0 mm, 13 ± 2.65 mm, 13 ± 1.0 mm, and 12 ± 1.0 mm, respectively. The excellent antifungal potential against Alternaria alternata, with maximum growth inhibition of 68.1% followed by 65.6% against Aspergillus niger, 64.3% Fusarium oxysporium and 64.1% against Ascochyta rabiei at the highest concentratin of 20 mg was observed. The maximum TAC was 73.5%, TRP 70.2%, DPPH 59.6%, and biocompatibility was 1.66 ± 0.10. Conclusively, the biosynthesized AgNPs have exhibited good potential (therapeutic and antimicrobial properties) and should be further inspected to improve their significance for practical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.